Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
摘要:
A series of thiadiazolopiperazinyl aryl urea fatty acid amide hydrolase ( FAAH) inhibitors is described. The molecules were found to inhibit the enzyme by acting as mechanism-based substrates, forming a covalent bond with Ser241. SAR and PK properties are presented. (C) 2008 Elsevier Ltd. All rights reserved.
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
摘要:
A series of thiadiazolopiperazinyl aryl urea fatty acid amide hydrolase ( FAAH) inhibitors is described. The molecules were found to inhibit the enzyme by acting as mechanism-based substrates, forming a covalent bond with Ser241. SAR and PK properties are presented. (C) 2008 Elsevier Ltd. All rights reserved.
Substituted Benzofused Derivatives and Their Use as Vanilloid Receptor Ligands
申请人:Gharat Laxmikant Atmaram
公开号:US20080269253A1
公开(公告)日:2008-10-30
The present invention relates to substituted benzofused derivatives, which can be used as vanilloid receptor ligands, method of treating diseases, conditions and/or disorders modulated by vanilloid receptors with them, and processes for preparing them.
SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS
申请人:GHARAT Laxmikant Atmaram
公开号:US20120041011A1
公开(公告)日:2012-02-16
The present invention relates to substituted benzofused derivatives, which can he used as vanilloid receptor ligands, method of treating diseases, conditions and/or disorders modulated by vanilloid receptors with them, and processes for preparing them.
[EN] SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS<br/>[FR] DÉRIVÉS BENZOFUSIONNÉS SUBSTITUÉS ET LEUR UTILISATION EN TANT QUE LIGANDS DES RÉCEPTEURS VANILLOÏDES
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2007042906A1
公开(公告)日:2007-04-19
[EN] The present invention relates to substituted benzofused derivatives, which can be used as vanilloid receptor ligands, method of treating diseases, conditions and/or disorders modulated by vanilloid receptors with them, and processes for preparing them. [FR] La présente invention concerne des dérivés benzofusionnés substitués qui peuvent être utilisés en tant que ligands des récepteurs vanilloïdes. L'invention concerne également un procédé de traitement à l'aide desdits dérivés de maladies, d'états et/ou de troubles modulés par les récepteurs vanilloïdes, ainsi que des procédés de préparation desdits dérivés.
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
作者:John M. Keith、Richard Apodaca、Wei Xiao、Mark Seierstad、Kanaka Pattabiraman、Jiejun Wu、Michael Webb、Mark J. Karbarz、Sean Brown、Sandy Wilson、Brian Scott、Chui-Se Tham、Lin Luo、James Palmer、Michelle Wennerholm、Sandra Chaplan、J. Guy Breitenbucher
DOI:10.1016/j.bmcl.2008.07.081
日期:2008.9
A series of thiadiazolopiperazinyl aryl urea fatty acid amide hydrolase ( FAAH) inhibitors is described. The molecules were found to inhibit the enzyme by acting as mechanism-based substrates, forming a covalent bond with Ser241. SAR and PK properties are presented. (C) 2008 Elsevier Ltd. All rights reserved.